Vanda Pharmaceuticals to Announce Second Quarter 2016 Financial Results on July 27, 2016

Loading...
Loading...

Conference Call and Webcast to Follow

WASHINGTON, July 12, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) VNDA today announced it will release results for the second quarter of 2016 on Wednesday, July 27, 2016, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Wednesday, July 27, 2016, during which management will discuss the second quarter 2016 financial results and other corporate activities. To participate in the conference call, please dial 1-888-771-4371 (domestic) or 1-847-585-4405 (international) and use passcode 42972056.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com.  Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, July 27, 2016, beginning at 7:00 PM ET and will be accessible until Wednesday, August 3, 2016, at 11:59 PM ET.  The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 42972056.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.  For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-second-quarter-2016-financial-results-on-july-27-2016-300297591.html

SOURCE Vanda Pharmaceuticals Inc.

Loading...
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...